home / stock / mnmd / mnmd articles

MNMD Articles, Mind Medicine (MindMed) Inc. - From 11/13/23

Stock Information
Company Name: Mind Medicine (MindMed) Inc.
Stock Symbol: MNMD
Market: NASDAQ
Website: mindmed.co
Menu
MNMD MNMD Quote MNMD Short MNMD News MNMD Articles MNMD Message Board
Get MNMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More | Benzinga

Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? An average of 17 veterans committed suicide per day in 2020...
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More | Benzinga

DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court The U.S. Court of Appeals for the Ninth Circuit ruled against the Drug Enforc...

MindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved | Benzinga

Clinical-stage psychedelics biotech Mind Medicine (MindMed) (NASDAQ: MNMD) has shared its financial outcomes for the third quarter ended September ...

Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More | Benzinga

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma In...
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted | Benzinga

Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts Jada Pinkett Smith has joined the growing numb...

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More | Benzinga

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) an...

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More | Benzinga

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary...
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More | Benzinga

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy...

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More | Benzinga

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Billionaire hedge fund and NY Mets own...

How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space | Benzinga

Artificial Intelligence (AI) is rapidly penetrating a number of different sectors, including healthcare. The use of AI in mental health has opened ...
Previous 10 Next 10